J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.

Intuitive Surgical's shares fell after Johnson & Johnson received FDA authorization for its Ottava surgical robot. Analysts doubt J&J's new product will significantly impact Intuitive's market due to surgeons' established preferences and training on Intuitive's da Vinci system.